MedTrace Logo

Intrathecal Analgesia Effects on Cancer Patients Discomfort Symptoms

NCT04491123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-07-29

No results posted yet for this study

Summary

Intrathecal analgesia is used in refractory cancer pain because of drug sides effects or intractable pain. The aim of this approach is to improve pain management, and also to improve patient comfort. This study will assess patient discomfort symptoms before and after setting up intrathecal analgesia.

Conditions

  • Refractory Cancer Pain
  • Intrathecal Analgesia

Sponsors & Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nīmes

    collaborator OTHER

  • Oncopole Toulouse

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Raphael RENAMBATZ-ICHAMBE · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-04-30
Completion
2020-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04491123 on ClinicalTrials.gov